Australia's MedAdvisor gains on annual profit jump

Adheris Health

31/07/2023 06:22

** Shares of MedAdvisor  MDR.AX  rise as much as 2.3% to
A$0.225 
    ** Medication technology co posts FY23 gross profit of
A$59.4 mln ($39.66 mln), up 81.4% from a year ago
    ** MDR says FY23 revenue rose 44.5% to A$98 mln 
    ** Stock down 15.4% YTD, as of last close
    
($1 = 1.4979 Australian dollars)

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))